TLV •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/27/2026 17:24
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTLV
Market Capitalization1,211.58 mln
Float31.45 mln
Earnings Date08/13/2026
EPS
1.05
Moderate
P / E
20.00
Premium valuation
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.32
Borderline
Relative Strength
42
/ 100
Slightly lagging
Debt / Equity
0.05
Debt-free
Business Description
Kamada Ltd. is an Israel-based biopharmaceutical company founded in 1990 that develops and produces protein-based therapies derived from human plasma, with a focus on treating and preventing serious conditions such as rabies, hepatitis B, hemophilia, and genetic protein deficiencies. The company markets its own portfolio of specialty medicines globally while also acting as a distributor of third-party biopharmaceutical products within Israel, covering a broad range of therapeutic areas including respiratory disease, immunology, cancer, and rare genetic disorders.
